Altın ve EURUSD önemli destekleri test ediyor! Ak Yatırım Araştırma Müdürümüz Uraz Çay uluslararası piyasalardaki gelişmeleri yorumluyor. TradeAll Spotify kanalındaki podcasti dinlemek için tıklayın. https://t.co/NMEV78z0c6
#TradeAll#AkYatırım#Podcast
Today I became the 1st female Cardiovascular Surgeon to implant a HM3 in an adult in Latam ❤️ 💪💪💪 an effort of a great Team in a great institution, w/ my husband assisting me! What an incredible day! So proud!!! @WomenAs1@WomenSurgeons@Womenintxp_mcs@WomenInThoracic
When calculating Cardiac Output, do you use Thermodilution? Est Fick? Direct Fick?
💥Our work from among the largest cath lab registries re: Thermodilution vs Fick CO w/ Directly Measured VO2
@MarkDrazner@JTThibs@WF_Parker@JLGrodin@RyanTedfordMD
📎https://t.co/tkik1nC9ej
Only on weekends! A STEMI in an LVAD Patient. A rare feared complication: an echo of LM occlusion: this is what almost-total LV infarction looks like! @UTHCardiology @HoustonShockHSS
When I asked my HF fellowship PD @dranulala about a resource to review HF studies released at the ACC Scientific Session 2022, she suggested: "Let's create one ourselves!" So, here's our attempt with @CardioNerds to do just that, with some infographics!
Great weekend at #ACC22 , where I had the pleasure to present a clinical case of cardiac sarcoidosis with some excellent #ACCFIT, as well as participate in a session discussing the importance of SGLT2i in HF !
Honored to be invited as section editor for @JACCJournals JACC:HF under leadership of @BiykemB 🙏🏽. Excited to contribute to her vision for the journal and share ideas. Look forward to even more mid&early career, cross border and global engagement and involvement@ACCinTouch
Heart failure is a bitter sweet field indeed. We rejoice when we can recover a patient with heart failure, help a patient find a new lease on life with an LVAD or transplant. But also find solace when we help the patient die with peace and dignity
Bristol Myers Squibb @bmsnews announced that the U.S. FDA has extended the review of the New Drug Application (NDA) for mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy to April 28, 2022.
Read more >> https://t.co/6wRLehdAk4